Loading clinical trials...
Loading clinical trials...
A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis
Conditions
Interventions
Test Product 49778
Test Product 10156
+1 more
Locations
22
United States
Fremont, California, United States
Los Angeles, California, United States
San Diego, California, United States
New Haven, Connecticut, United States
Aventura, Florida, United States
Augusta, Georgia, United States
Start Date
September 1, 2012
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
January 9, 2013
NCT05319444
NCT04445987
NCT00565279
Lead Sponsor
Medicis Global Service Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions